Literature DB >> 27394409

Association Between Heart Rate at Rest and Incident Atrial Fibrillation (from the Copenhagen Electrocardiographic Study).

Morten W Skov1, Troels N Bachmann2, Peter V Rasmussen2, Morten S Olesen2, Adrian Pietersen3, Claus Graff4, Bent Lind3, Johannes J Struijk4, Lars Køber5, Stig Haunsø6, Jesper H Svendsen6, Thomas A Gerds7, Anders G Holst2, Jonas B Nielsen8.   

Abstract

Heart rate (HR) at rest is a well-known marker of cardiovascular morbidity and mortality. Results on the association between HR and incident atrial fibrillation (AF) have, however, been conflicting. Using digital electrocardiograms from 281,451 primary care patients, we aimed to describe the association between HR at rest and the hazards of incident AF. Secondary end points were death from all causes and pacemaker implantation. Data on drug use, co-morbidity, and outcomes were collected from nationwide administrative health care registries. During a median follow-up time of 8.4 years, 15,666 subjects were observed to develop AF, of which 1,631 were lone AF. A HR at rest from 30 to 51 beats/min was associated with an adjusted hazard ratio of 1.16 (95% CI 1.06 to 1.27) for AF compared with the reference group (66 to 72 beats/min). From 72 beats/min and upward, the hazard ratio of AF increased in a dose-response manner, reaching an adjusted hazard ratio of 1.36 (95% CI 1.26 to 1.46) for HR between 95 and 120 beats/min. Both for low and high HR, the associations were accentuated for the outcome lone AF (adjusted hazard ratios of 1.48, 95% CI 1.19 to 1.84 and 1.84, 95% CI 1.47 to 2.30 for HR between 30 to 51 and 95 to 120 beats/min, respectively). For death from all causes, the hazard increased almost linearly with increasing HR. A HR at rest from 30 to 51 beats/min was associated with an adjusted hazard ratio of 1.80 (95% CI 1.46 to 2.21) for pacemaker implantation. In conclusion, a U-shaped association was found between HR at rest and incident AF, and this association was strongest for the outcome lone AF.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27394409     DOI: 10.1016/j.amjcard.2016.06.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Resting Heart Rate, Short-Term Heart Rate Variability and Incident Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis (MESA)).

Authors:  Mohammadali Habibi; Harjit Chahal; Philip Greenland; Eliseo Guallar; João A C Lima; Elsayed Z Soliman; Alvaro Alonso; Susan R Heckbert; Saman Nazarian
Journal:  Am J Cardiol       Date:  2019-09-06       Impact factor: 2.778

2.  Minimum heart rate and mortality in critically ill myocardial infarction patients: an analysis of the MIMIC-III database.

Authors:  Junjie Wang; Lingqu Zhou; Yinyin Zhang; Haifeng Zhang; Yong Xie; Zhiteng Chen; Boshui Huang; Kuan Zeng; Juan Lei; Jingting Mai; Yue Pan; Yangxin Chen; Jingfeng Wang; Qi Guo
Journal:  Ann Transl Med       Date:  2021-03

3.  Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure.

Authors:  Hyo-In Choi; Sang Eun Lee; Min-Seok Kim; Hae-Young Lee; Hyun-Jai Cho; Jin Oh Choi; Eun-Seok Jeon; Kyung-Kuk Hwang; Shung Chull Chae; Sang Hong Baek; Seok-Min Kang; Dong-Ju Choi; Byung-Su Yoo; Kye Hun Kim; Myeong-Chan Cho; Byung-Hee Oh; Jae-Joong Kim
Journal:  Life (Basel)       Date:  2022-04-13

4.  Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.

Authors:  J E Siland; B Geelhoed; C Roselli; B Wang; H J Lin; S Weiss; S Trompet; M E van den Berg; E Z Soliman; L Y Chen; I Ford; J W Jukema; P W Macfarlane; J Kornej; H Lin; K L Lunetta; M Kavousi; J A Kors; M A Ikram; X Guo; J Yao; M Dörr; S B Felix; U Völker; N Sotoodehnia; D E Arking; B H Stricker; S R Heckbert; S A Lubitz; E J Benjamin; A Alonso; P T Ellinor; P van der Harst; M Rienstra
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.240

Review 5.  Mechanisms of atrial fibrillation in athletes: what we know and what we do not know.

Authors:  E Guasch; L Mont; M Sitges
Journal:  Neth Heart J       Date:  2018-03       Impact factor: 2.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.